{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T11:16:31Z","timestamp":1792062991493,"version":"4.4.0"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,6,3]]},"DOI":"10.7759\/cureus.25633","type":"journal-article","created":{"date-parts":[[2022,6,3]],"date-time":"2022-06-03T16:22:20Z","timestamp":1654273340000},"source":"Crossref","is-referenced-by-count":14,"title":["Cardiovascular Morbidity in Ankylosing Spondylitis: A Focus on Inflammatory Cardiac Disease"],"prefix":"10.7759","author":[{"given":"Pradnya Brijmohan","family":"Bhattad","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mugdha","family":"Kulkarni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Parasbhai D","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mazen","family":"Roumia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"crossref","DOI":"10.1016\/S0140-6736(07)60635-7","article-title":"Ankylosing spondylitis","volume":"369","author":"Braun J","year":"2007","unstructured":"Braun J, Sieper J. Ankylosing spondylitis. Lancet. 2007, 369:1379-90.","journal-title":"Lancet"},{"key":"ref2","article-title":"The spondyloarthritides","author":"Jameson JL","year":"2018","unstructured":"Jameson JL, Kasper DL, Longo DL, Fauci AS, Hauser SL. The spondyloarthritides. Harrison's Principles of Internal Medicine, Twentieth Edition. Loscalzo J (ed): McGraw-Hill Education, New York, NY; 2018."},{"key":"ref3","doi-asserted-by":"crossref","DOI":"10.7326\/M14-2470","article-title":"Patients with ankylosing spondylitis have increased cardiovascular and cerebrovascular mortality: a population-based study","volume":"163","author":"Haroon NN","year":"2015","unstructured":"Haroon NN, Paterson JM, Li P, Inman RD, Haroon N. Patients with ankylosing spondylitis have increased cardiovascular and cerebrovascular mortality: a population-based study. Ann Intern Med. 2015, 163:409-16.","journal-title":"Ann Intern Med"},{"key":"ref4","article-title":"Cardiovascular morbidity, and mortality in patients with spondylarthritis: a meta-analysis","volume":"24","author":"Kim JH","year":"2020","unstructured":"Kim JH, Choi IA. Cardiovascular morbidity, and mortality in patients with spondylarthritis: a meta-analysis. Int J Rheum Dis. 2020, 24:477-86.","journal-title":"Int J Rheum Dis"},{"key":"ref5","doi-asserted-by":"crossref","DOI":"10.1007\/s00296-002-0237-4","article-title":"Age at disease onset and diagnosis delay in HLA-B27 negative vs. positive patients with ankylosing spondylitis","volume":"23","author":"Feldtkeller E","year":"2003","unstructured":"Feldtkeller E, Khan MA, van der Heijde D, van der Linden S, Braun J. Age at disease onset and diagnosis delay in HLA-B27 negative vs. positive patients with ankylosing spondylitis. Rheumatol Int. 2003, 23:61-6.","journal-title":"Rheumatol Int"},{"key":"ref6","article-title":"The epidemiology of ankylosing spondylitis","volume":"22","author":"Gran JT","year":"1993","unstructured":"Gran JT, Husby G. The epidemiology of ankylosing spondylitis. Semin Arthritis Rheum. 1993, 22:319-34.","journal-title":"Semin Arthritis Rheum"},{"key":"ref7","article-title":"The spondyloarthropathies","author":"Goldman L","year":"2019","unstructured":"Goldman L, Schafer A. The spondyloarthropathies. Goldman and Cecil. Elsevier, Amsterdam; 2019."},{"key":"ref8","doi-asserted-by":"crossref","DOI":"10.1002\/art.21174","article-title":"Juvenile-onset ankylosing spondylitis is associated with worse functional outcomes than adult-onset ankylosing spondylitis","volume":"53","author":"Stone M","year":"2005","unstructured":"Stone M, Warren RW, Bruckel J, Cooper D, Cortinovis D, Inman RD. Juvenile-onset ankylosing spondylitis is associated with worse functional outcomes than adult-onset ankylosing spondylitis. Arthritis Rheum. 2005, 53:445-51.","journal-title":"Arthritis Rheum"},{"key":"ref9","doi-asserted-by":"crossref","DOI":"10.1016\/j.amjmed.2015.04.032","article-title":"Aortic regurgitation is common in ankylosing spondylitis: time for routine echocardiography evaluation?","volume":"128","author":"Klingberg E","year":"2015","unstructured":"Klingberg E, Bente GS, T\u00e4ng MS, Bech-Hanssen O, d\u2019Elia HF, Bergfeldt L. Aortic regurgitation is common in ankylosing spondylitis: time for routine echocardiography evaluation?. Am J Med. 2015, 128:1244-50.","journal-title":"Am J Med"},{"key":"ref10","doi-asserted-by":"crossref","DOI":"10.1136\/annrheumdis-2012-201884","article-title":"ASAS modification of the Berlin algorithm for diagnosing axial spondyloarthritis: results from the SPondyloArthritis Caught Early (SPACE)-cohort and from the Assessment of SpondyloArthritis international Society (ASAS)-cohort","volume":"72","author":"van den Berg R","year":"2013","unstructured":"van den Berg R, de Hooge M, Rudwaleit M, et al.. ASAS modification of the Berlin algorithm for diagnosing axial spondyloarthritis: results from the SPondyloArthritis Caught Early (SPACE)-cohort and from the Assessment of SpondyloArthritis international Society (ASAS)-cohort. Ann Rheum Dis. 2013, 72:1646-53.","journal-title":"Ann Rheum Dis"},{"key":"ref11","article-title":"Evaluation of diagnostic criteria for ankylosing spondylitis: a proposal for modification of the New York criteria","volume":"27","author":"van der Linden S","year":"1984","unstructured":"van der Linden S, Valkenburg HA, Cats A. Evaluation of diagnostic criteria for ankylosing spondylitis: a proposal for modification of the New York criteria. Arthritis Rheum. 1984, 27:361-8.","journal-title":"Arthritis Rheum"},{"key":"ref12","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMra1406182","article-title":"Ankylosing spondylitis and axial spondyloarthritis","volume":"374","author":"Taurog JD","year":"2016","unstructured":"Taurog JD, Chhabra A, Colbert RA. Ankylosing spondylitis and axial spondyloarthritis. N Engl J Med. 2016, 374:2563-74.","journal-title":"N Engl J Med"},{"key":"ref13","article-title":"The development of Assessment of SpondyloArthritis international Society classification criteria for axial spondyloarthritis (part II): validation and final selection","volume":"68","author":"Rudwaleit M","year":"2009","unstructured":"Rudwaleit M, van der Heijde D, Landew\u00e9 R, et al.. The development of Assessment of SpondyloArthritis international Society classification criteria for axial spondyloarthritis (part II): validation and final selection. Ann Rheum Dis. 2009, 68:777-83.","journal-title":"Ann Rheum Dis"},{"key":"ref14","doi-asserted-by":"crossref","DOI":"10.1136\/ard.61.suppl_3.iii8","article-title":"Ankylosing spondylitis: an overview","volume":"61","author":"Sieper J","year":"2002","unstructured":"Sieper J, Braun J, Rudwaleit M, Boonen A, Zink A. Ankylosing spondylitis: an overview. Ann Rheum Dis. 2002, 61:8-18.","journal-title":"Ann Rheum Dis"},{"key":"ref15","doi-asserted-by":"crossref","DOI":"10.1136\/ard.59.2.135","article-title":"Quantitative analyses of sacroiliac biopsies in spondyloarthropathies: T cells and macrophages predominate in early and active sacroiliitis- cellularity correlates with the degree of enhancement detected by magnetic resonance imaging","volume":"59","author":"Bollow M","year":"2000","unstructured":"Bollow M, Fischer T, Reisshauer H, Backhaus M, Sieper J, Hamm B, Braun J. Quantitative analyses of sacroiliac biopsies in spondyloarthropathies: T cells and macrophages predominate in early and active sacroiliitis- cellularity correlates with the degree of enhancement detected by magnetic resonance imaging. Ann Rheum Dis. 2000, 59:135-40.","journal-title":"Ann Rheum Dis"},{"key":"ref16","article-title":"Genetic association of ankylosing spondylitis with TBX21 influences T-bet and pro-inflammatory cytokine expression in humans and SKG mice as a model of spondyloarthritis","volume":"76","author":"Lau MC","year":"2017","unstructured":"Lau MC, Keith P, Costello M, et al.. Genetic association of ankylosing spondylitis with TBX21 influences T-bet and pro-inflammatory cytokine expression in humans and SKG mice as a model of spondyloarthritis. Ann Rheum Dis. 2017, 76:261-9.","journal-title":"Ann Rheum Dis"},{"key":"ref17","doi-asserted-by":"crossref","DOI":"10.1007\/s10067-020-05369-w","article-title":"Increasing of SIgA serum levels may reflect subclinical intestinal involvement in non-radiographic axial and peripheral spondyloarthritis","volume":"40","author":"Arias I","year":"2021","unstructured":"Arias I, Herrera D, Bautista-Molano W, et al.. Increasing of SIgA serum levels may reflect subclinical intestinal involvement in non-radiographic axial and peripheral spondyloarthritis. Clin Rheumatol. 2021, 40:1343-51.","journal-title":"Clin Rheumatol"},{"key":"ref18","doi-asserted-by":"crossref","DOI":"10.1002\/1529-0131(200004)43:4<720::AID-ANR2>3.0.CO;2-8","article-title":"Report on the Fourth International Workshop on reactive arthritis","volume":"43","author":"Sieper J","year":"2000","unstructured":"Sieper J, Braun J, Kingsley GH. Report on the Fourth International Workshop on reactive arthritis. Arthritis Rheum. 2000, 43:720-34.","journal-title":"Arthritis Rheum"},{"key":"ref19","doi-asserted-by":"crossref","DOI":"10.1007\/s00296-010-1416-3","article-title":"Atherosclerosis and endothelial dysfunction in patients with ankylosing spondylitis","volume":"30","author":"Azevedo VF","year":"2010","unstructured":"Azevedo VF, Pecoits-Filho R. Atherosclerosis and endothelial dysfunction in patients with ankylosing spondylitis. Rheumatol Int. 2010, 30:1411-6.","journal-title":"Rheumatol Int"},{"key":"ref20","article-title":"Population\u2010based estimates of common comorbidities and cardiovascular disease in ankylosing spondylitis","volume":"63","author":"20. Bremander A","year":"2011","unstructured":"20. Bremander A, Petersson IF, Bergman S, Englund M. Population\u2010based estimates of common comorbidities and cardiovascular disease in ankylosing spondylitis. Arthritis Care Res. 2011, 63:550-6.","journal-title":"Arthritis Care Res"},{"key":"ref21","article-title":"Atherosclerosis and cardiovascular disease in the spondyloarthritides, particularly ankylosing spondylitis and psoriatic arthritis","volume":"31","author":"Papagoras C","year":"2013","unstructured":"Papagoras C, Voulgari PV, Drosos AA. Atherosclerosis and cardiovascular disease in the spondyloarthritides, particularly ankylosing spondylitis and psoriatic arthritis. Clin Exp Rheumatol. 2013, 31:612-20.","journal-title":"Clin Exp Rheumatol"},{"key":"ref22","doi-asserted-by":"crossref","DOI":"10.1042\/CS20040326","article-title":"Cardiovascular risk parameters in men with ankylosing spondylitis in comparison with non-inflammatory control subjects: relevance of systemic inflammation","volume":"109","author":"Divecha H","year":"2005","unstructured":"Divecha H, Sattar N, Rumley A, Cherry L, Lowe GD, Sturrock R. Cardiovascular risk parameters in men with ankylosing spondylitis in comparison with non-inflammatory control subjects: relevance of systemic inflammation. Clin Sci (Lond). 2005, 109:171-6.","journal-title":"Clin Sci (Lond)"},{"key":"ref23","doi-asserted-by":"crossref","DOI":"10.1016\/S0021-9150(99)00463-3","article-title":"Inflammation, obesity, stress, and coronary heart disease: is interleukin-6 the link?","volume":"148","author":"Yudkin JS","year":"2000","unstructured":"Yudkin JS, Kumari M, Humphries SE, Mohamed-Ali V. Inflammation, obesity, stress, and coronary heart disease: is interleukin-6 the link?. Atherosclerosis. 2000, 148:209-14.","journal-title":"Atherosclerosis"},{"key":"ref24","doi-asserted-by":"crossref","DOI":"10.1086\/315611","article-title":"Infection and inflammation-induced proatherogenic changes of lipoproteins","volume":"181","author":"Khovidhunkit W","year":"2000","unstructured":"Khovidhunkit W, Memon RA, Feingold KR, Grunfeld C. Infection and inflammation-induced proatherogenic changes of lipoproteins. J Infect Dis. 2000, 181:462-72.","journal-title":"J Infect Dis"},{"key":"ref25","doi-asserted-by":"crossref","DOI":"10.1161\/01.CIR.0000099844.31524.05","article-title":"Explaining how \"high-grade\" systemic inflammation accelerates vascular risk in rheumatoid arthritis","volume":"108","author":"Sattar N","year":"2003","unstructured":"Sattar N, McCarey DW, Capell H, McInnes IB. Explaining how \"high-grade\" systemic inflammation accelerates vascular risk in rheumatoid arthritis. Circulation. 2003, 108:2957-63.","journal-title":"Circulation"},{"key":"ref26","doi-asserted-by":"crossref","DOI":"10.3899\/jrheum.150316","article-title":".Subclinical atherosclerosis is not accelerated in patients with ankylosing spondylitis with low disease activity: new data and metaanalysis of published studies","volume":"42","author":"Arida A","year":"2015","unstructured":"Arida A, Protogerou AD, Konstantonis G, Konsta M, Delicha EM, Kitas GD, Sfikakis PP. .Subclinical atherosclerosis is not accelerated in patients with ankylosing spondylitis with low disease activity: new data and metaanalysis of published studies. J Rheumatol. 2015, 42:2098-105.","journal-title":"J Rheumatol"},{"key":"ref27","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0b013e3181c10773","article-title":"The high prevalence of subclinical atherosclerosis in patients with ankylosing spondylitis without clinically evident cardiovascular disease","volume":"88","author":"Gonzalez-Juanatey C","year":"2009","unstructured":"Gonzalez-Juanatey C, Vazquez-Rodriguez TR, Miranda-Filloy JA, et al.. The high prevalence of subclinical atherosclerosis in patients with ankylosing spondylitis without clinically evident cardiovascular disease. Medicine (Baltimore). 2009, 88:358-65.","journal-title":"Medicine (Baltimore)"},{"key":"ref28","article-title":"Cardiovascular disease and risk factors in patients with rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis","volume":"33","author":"Han C","year":"2006","unstructured":"Han C, Robinson DW Jr, Hackett MV, Paramore LC, Fraeman KH, Bala MV. Cardiovascular disease and risk factors in patients with rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis. J Rheumatol. 2006, 33:2167-72.","journal-title":"J Rheumatol"},{"key":"ref29","doi-asserted-by":"crossref","DOI":"10.3899\/jrheum.130588","article-title":"Ankylosing spondylitis and nonradiographic axial spondyloarthritis: part of a common spectrum or distinct diseases?","volume":"40","author":"Wallis D","year":"2013","unstructured":"Wallis D, Haroon N, Ayearst R, Carty A, Inman RD. Ankylosing spondylitis and nonradiographic axial spondyloarthritis: part of a common spectrum or distinct diseases?. J Rheumatol. 2013, 40:2038-41.","journal-title":"J Rheumatol"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1136\/rmdopen-2016-000319","article-title":"Serum inflammatory biomarkers fail to identify early axial spondyloarthritis: results from the SpondyloArthritis Caught Early (SPACE) cohort","volume":"3","author":"Turina MC","year":"2017","unstructured":"Turina MC, Yeremenko N, van Gaalen F, et al.. Serum inflammatory biomarkers fail to identify early axial spondyloarthritis: results from the SpondyloArthritis Caught Early (SPACE) cohort. RMD Open. 2017, 3:e000319. 10.1136\/rmdopen-2016-000319","journal-title":"RMD Open"},{"key":"ref31","doi-asserted-by":"crossref","DOI":"10.3899\/jrheum.110792","article-title":"Assessment of preclinical atherosclerosis in patients with ankylosing spondylitis","volume":"39","author":"Hamdi W","year":"2012","unstructured":"Hamdi W, Bouaziz MC, Zouch I, Ghannouchi MM, Haouel M, Ladeb MF, Kchir MM. Assessment of preclinical atherosclerosis in patients with ankylosing spondylitis. J Rheumatol. 2012, 39:322-6.","journal-title":"J Rheumatol"},{"key":"ref32","doi-asserted-by":"crossref","DOI":"10.1016\/S0140-6736(18)31946-9","article-title":"Ixekizumab, an interleukin-17A antagonist in the treatment of ankylosing spondylitis or radiographic axial spondyloarthritis in patients previously untreated with biological disease-modifying anti-rheumatic drugs (COAST-V): 16 week results of a phase 3 randomised, double-blind, active-controlled and placebo-controlled trial","volume":"392","author":"van der Heijde D","year":"2018","unstructured":"van der Heijde D, Wei JC, Dougados M, et al.. Ixekizumab, an interleukin-17A antagonist in the treatment of ankylosing spondylitis or radiographic axial spondyloarthritis in patients previously untreated with biological disease-modifying anti-rheumatic drugs (COAST-V): 16 week results of a phase 3 randomised, double-blind, active-controlled and placebo-controlled trial. Lancet. 2018, 392:2441-51.","journal-title":"Lancet"},{"key":"ref33","article-title":"Ankylosing spondylitis--cardiac manifestations","volume":"20","author":"Lautermann D","year":"2002","unstructured":"Lautermann D, Braun J. Ankylosing spondylitis--cardiac manifestations. Clin Exp Rheumatol. 2002, 20:11-5.","journal-title":"Clin Exp Rheumatol"},{"key":"ref34","doi-asserted-by":"crossref","DOI":"10.1007\/BF02330598","article-title":"Cardiovascular manifestations of ankylosing spondylitis","volume":"6","author":"Sukenik S","year":"1987","unstructured":"Sukenik S, Pras A, Buskila D, Katz A, Snir Y, Horowitz J. Cardiovascular manifestations of ankylosing spondylitis. Clin Rheumatol. 1987, 6:588-92.","journal-title":"Clin Rheumatol"},{"key":"ref35","doi-asserted-by":"crossref","DOI":"10.1016\/0002-9343(85)90211-6","article-title":"Two-dimensional echocardiographic detection of preclinical aortic root abnormalities in rheumatoid variant diseases","volume":"78","author":"LaBresh KA","year":"1985","unstructured":"LaBresh KA, Lally EV, Sharma SC, Ho G Jr. Two-dimensional echocardiographic detection of preclinical aortic root abnormalities in rheumatoid variant diseases. Am J Med. 1985, 78:908-12.","journal-title":"Am J Med"},{"key":"ref36","doi-asserted-by":"crossref","DOI":"10.2143\/AC.64.3.2038026","article-title":"Effects of ankylosing spondylitis on the heart","volume":"64","author":"Gunes Y","year":"2009","unstructured":"Gunes Y, Tuncer M, Guntenkin U, Sahin M, Tazmalar L. Effects of ankylosing spondylitis on the heart. Acta Cardiologica. 2009, 64:385-92.","journal-title":"Acta Cardiologica"},{"key":"ref37","article-title":"Ankylosing spondylitis and risk of ischaemic heart disease: a population-based cohort study","volume":"75","author":"Essers I","year":"2014","unstructured":"Essers I, Stolwijk C, Boonen A, De Bruin M L., Bazelier M T., de Vries F. ven Tubergen A. Ankylosing spondylitis and risk of ischaemic heart disease: a population-based cohort study. Annals of Rheumatology Disease. 2014, 75:203-9.","journal-title":"Annals of Rheumatology Disease"},{"key":"ref38","doi-asserted-by":"crossref","DOI":"10.1002\/acr.20364","article-title":"Cardiovascular profile in ankylosing spondylitis: a systematic review and meta-analysis","volume":"63","author":"Mathieu S","year":"2011","unstructured":"Mathieu S, Gossec L, Dougados M, Soubrier M. Cardiovascular profile in ankylosing spondylitis: a systematic review and meta-analysis. Arthritis Care Res (Hoboken). 2011, 63:557-63.","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"ref39","doi-asserted-by":"crossref","DOI":"10.1016\/j.semarthrit.2012.02.008","article-title":"No increased rate of acute myocardial infarction or stroke among patients with ankylosing spondylitis-a retrospective cohort study using routine data","volume":"42","author":"Brophy S","year":"2012","unstructured":"Brophy S, Cooksey R, Atkinson M, et al.. No increased rate of acute myocardial infarction or stroke among patients with ankylosing spondylitis-a retrospective cohort study using routine data. Semin Arthritis Rheum. 2012, 42:140-5.","journal-title":"Semin Arthritis Rheum"},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0064155","article-title":"Increased risk of ischemic heart disease in young patients with newly diagnosed ankylosing spondylitis--a population-based longitudinal follow-up study","volume":"8","author":"Huang YP","year":"2013","unstructured":"Huang YP, Wang YH, Pan SL. Increased risk of ischemic heart disease in young patients with newly diagnosed ankylosing spondylitis--a population-based longitudinal follow-up study. PLoS One. 2013, 8:e64155. 10.1371\/journal.pone.0064155","journal-title":"PLoS One"},{"key":"ref41","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbspin.2020.03.012","article-title":"Role of HLA-B27 in the comorbidities observed in axial spondyloarthritis: data from COMOSPA","volume":"87","author":"Ar\u00e9valo M","year":"2020","unstructured":"Ar\u00e9valo M, L\u00f3pez-Medina C, Moreno Martinez-Losa M, Molt\u00f3 A, Font P, Collantes-Estevez E, Gratac\u00f3s J. Role of HLA-B27 in the comorbidities observed in axial spondyloarthritis: data from COMOSPA. Joint Bone Spine. 2020, 87:445-8.","journal-title":"Joint Bone Spine"},{"key":"ref42","doi-asserted-by":"crossref","DOI":"10.1136\/ard.52.3.174","article-title":"Mortality and causes of death in 398 patients admitted to hospital with ankylosing spondylitis","volume":"52","author":"Lehtinen K","year":"1993","unstructured":"Lehtinen K. Mortality and causes of death in 398 patients admitted to hospital with ankylosing spondylitis. Ann Rheum Dis. 1993, 52:174-6.","journal-title":"Ann Rheum Dis"},{"key":"ref43","doi-asserted-by":"crossref","DOI":"10.1136\/ard.2011.151191","article-title":"Increased mortality in ankylosing spondylitis is related to disease activity","volume":"70","author":"Bakland G","year":"2011","unstructured":"Bakland G, Gran JT, Nossent JC. Increased mortality in ankylosing spondylitis is related to disease activity. Ann Rheum Dis. 2011, 70:1921-5.","journal-title":"Ann Rheum Dis"},{"key":"ref44","doi-asserted-by":"crossref","DOI":"10.1186\/1471-2474-14-237","article-title":"Cardiac conduction system abnormalities in ankylosing spondylitis: a cross-sectional study","volume":"14","author":"Forsblad-d\u2019Elia","year":"2013","unstructured":"Forsblad-d\u2019Elia, Wallberg H, Klingberg E, et al.. Cardiac conduction system abnormalities in ankylosing spondylitis: a cross-sectional study. BMC Musculoskelet Disord. 2013, 14:237.","journal-title":"BMC Musculoskelet Disord"},{"key":"ref45","doi-asserted-by":"publisher","DOI":"10.1136\/rmdopen-2019-001053","article-title":"Cardiac conduction disturbances in patients with ankylosing spondylitis: results from a 5-year follow-up cohort study","volume":"5","author":"Bengtsson K","year":"2019","unstructured":"Bengtsson K, Klingberg E, Deminger A, Wallberg H, Jacobsson LT, Bergfeldt L, Forsblad-d'Elia H. Cardiac conduction disturbances in patients with ankylosing spondylitis: results from a 5-year follow-up cohort study. RMD Open. 2019, 5:e001053. 10.1136\/rmdopen-2019-001053","journal-title":"RMD Open"},{"key":"ref46","doi-asserted-by":"publisher","DOI":"10.31744\/einstein_journal\/2019AO4539","article-title":"Electrocardiographic changes in spondyloarthritis and use of anti-TNF-\u03b1 drugs: a retrospective study with 100 patients","volume":"17","author":"Longo B","year":"2019","unstructured":"Longo B, Kirchner LA, Simioni J, Campos AP, Skare TL. Electrocardiographic changes in spondyloarthritis and use of anti-TNF-\u03b1 drugs: a retrospective study with 100 patients. Einstein (Sao Paulo). 2019, 17:eAO4539. 10.31744\/einstein_journal\/2019AO4539","journal-title":"Einstein (Sao Paulo)"},{"key":"ref47","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbspin.2010.01.001","article-title":"Usefulness of routine electrocardiography for heart disease screening in patients with spondyloarthropathy or rheumatoid arthritis","volume":"77","author":"Goulenok TM","year":"2010","unstructured":"Goulenok TM, Meune C, Gossec L, et al.. Usefulness of routine electrocardiography for heart disease screening in patients with spondyloarthropathy or rheumatoid arthritis. Joint Bone Spine. 2010, 77:146-50.","journal-title":"Joint Bone Spine"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/96596-cardiovascular-morbidity-in-ankylosing-spondylitis-a-focus-on-inflammatory-cardiac-disease","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:43:55Z","timestamp":1707507835000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/96596-cardiovascular-morbidity-in-ankylosing-spondylitis-a-focus-on-inflammatory-cardiac-disease"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,3]]},"references-count":47,"URL":"https:\/\/doi.org\/10.7759\/cureus.25633","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2022,6,3]]}}}